ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

KYTX Kyverna Therapeutics Inc

7.89
0.16 (2.07%)
24 Jun 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 00
Operating Income -21.38M-29.36M
Pre Tax Income -20.67M-26.69M
Net Income -20.67M-26.69M
Preferred Dividends 00
Basic Earnings Per Share (EPS) 00
EBIT -21.41M-29.38M
EBITDA -21.08M-28.88M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 5.66M7.03M0
Operating Income -26.35M-29.38M-62.41M
Pre Tax Income -26.35M-28.89M-60.37M
Net Income -26.35M-28.89M-60.37M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -10.209-6.302-11.52
EBIT -26.35M-29.39M-62.46M
EBITDA -25.76M-28.58M-61.51M